66546 Federal Register / Vol. 65, No. 215 / Monday, November 6, 2000 / Notices

questionnaire (OMB 0923–0016) to get

readers’ opinions and evaluations. The

survey will be inserted and mailed in

each public health assessment. In

addition, electronic surveys will be sent

to clients and partners requesting

ATSDR health consultations and

exposure investigations within one

month following delivery of product or

service. The survey collects information

on (a) affiliation of users, (b) timeliness

and effectiveness of these products, and

(c) practical utility of these products.

The reader evaluation surveys provide

important feedback that enables ATSDR

staff to maintain the utility, integrity

and standards of its products. Gathering

client feedback ensures that appropriate

information is included in these

documents and assists in maintaining

medical and scientific usefulness. The

information will be used to maintain

customer satisfaction with these

products. There is no cost to

respondents.

The estimate annual burden is 172

hours.

Respondents Number of

respondents

Responses

per

respondent

Avg. burden

response

(in hrs.)

Total burden

(in hrs.)

ATSDR clients and partners ............................................................................ 300 1 0.25 75

Librarians ......................................................................................................... 180 1 0.12 22

Individuals completing questionnaires ............................................................. 200 1 0.25 50

Individuals who received but did not complete questionnaires ....................... 100 1 0.25 25

Dated: October 30, 2000.

Kathy Cahill,

Associate Director for Policy, Planning, and

Evaluation, Centers for Disease Control and

Prevention (CDC).

[FR Doc. 00–28363 Filed 11–03–00; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

[30DAY–06–01]

Agency Forms Undergoing Paperwork

Reduction Act Review

The Centers for Disease Control and

Prevention (CDC) publishes a list of

information collection requests under

review by the Office of Management and

Budget (OMB) in compliance with the

Paperwork Reduction Act (44 U.S.C.

Chapter 35). To request a copy of these

requests, call the CDC Reports Clearance

Officer at (404) 639–7090. Send written

comments to CDC, Desk Officer; Human

Resources and Housing Branch, New

Executive Office Building, Room 10235;

Washington, DC 20503. Written

comments should be received within 30

days of this notice.

Proposed Project

Jail STD Prevalence Monitoring

System—New—National Center for HIV,

STD, and TB Prevention (NCHSTP)

Proposes a 3-year clearance for data

collection of the standardized record

layout for the Jail STD Prevalence

Monitoring System. This system

consists of test data compiled for

persons entering corrections facilities.

The standard data elements were

created in response to the need to

systematically assess morbidity in

persons entering corrections facilities

who are at high risk for STDs and who

often do not seek medical care in

mainstream medical settings.

Use of these standard data elements

will improve surveillance of STDs by

allowing for systematic assessment of a

high risk population, taking advantage

of already computerized data. States

that compile data from corrections

facilities are encouraged to participate

in the system. The estimated annualized

burden is 1248 hours.

Respondents Number of

respondents

Average Number of forms/

respondent

Number of

responses/

respondent

Average burden/response

(in hrs.)

State/local health departments ......................................................................... 65 16 1 1.2

Dated: October 30, 2000.

Kathy Cahill,

Associate Director for Policy, Planning and

Evaluation, Centers for Disease Control and

Prevention (CDC).

[FR Doc. 00–28436 Filed 11–03–00; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Administration for Children and

Families

Proposed Information Collection

Activity; Comment Request

Proposed Projects

Title: Case Plan Section

422,471(a)(16), 475(5)(A) of the Social

Security Act.

OMB No.: 0980–0140.

Description: Under section 471(a)(16)

of title IV–E of the Social Security Act

(the Act), in order for States to be

eligible for payments they must have an

approved State plan which provides for

the development of a case plan (as

defined in section 475(1)) for each child

receiving foster care maintenance

payments, and provides a case review

system which meets the requirements in

section 475(5) and 475(6). Through the

meeting of these requirements, the State

also complies, in part, with title IV–B,

section 422(b)(10) of the Act (as of

4/1/96), which assures certain

protections for children in foster care.

Respondents: State governments.

Federal Register / Vol. 65, No. 215 / Monday, November 6, 2000 / Notices 66547

ANNUAL BURDEN ESTIMATES

Instrument Number of

respondents

Number of responses per

respondents

Average burden hours per

response

Total burden

hours

Case Plan ........................................................................................................ 714,056 1 2.62 1,870,827

Estimated Total Annual Burden Hours: .................................................... ........................ ........................ ........................ 1,870,827

In compliance with the requirements

of Section 3506(c)(2)(A) of the

Paperwork Reduction Act of 1995, the

Administration for Children and

Families is soliciting public comment

on the specific aspects of the

information collection described above.

Copies of the proposed collection of

information can be obtained and

comments may be forwarded by writing

to the Administration for Children and

Families, Office of Information Services,

370 L’Enfant Promenade, SW.,

Washington, DC 20447, Attn: ACF

Reports Clearance Officer. All requests

should be identified by the title of the

information collection.

The Department specifically requests

comments on: (a) Whether the proposed

collection of information is necessary

for the proper performance of the

functions of the agency, including

whether the information shall have

practical utility; (b) the accuracy of the

agency’s estimate of the burden of the

proposed collection of information; (c)

the quality, utility, and clarity of the

information to be collected; and (d)

ways to minimize the burden of the

collection of information on

respondents, including through the use

of automated collection techniques or

other forms of information technology.

Consideration will be given to

comments and suggestions submitted

within 60 days of this publication.

Dated: October 30, 2000.

Bob Sargis,

Reports Clearance Officer.

[FR Doc. 00–28317 Filed 11–3–00; 8:45 am]

BILLING CODE 4184–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food and Drug Administration

Neurological Devices Panel of the

Medical Devices Advisory Committee;

Notice of Meeting

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

This notice announces a forthcoming

meeting of a public advisory committee

of the Food and Drug Administration

(FDA). At least one portion of the

meeting will be closed to the public.

Name of Committee: Neurological

Devices Panel of the Medical Devices

Advisory Committee.

General Function of the Committee:

To provide advice and

recommendations to the agency on

FDA’s regulatory issues.

Date and Time: The meeting will be

held on November 16, 2000, 9:30 a.m.

to 7 p.m.

Location: Quality Suites Hotel,

Potomac Rooms II and III, Three

Research Ct., Rockville, MD.

Contact Person: Janet L. Scudiero,

Center for Devices and Radiological

Health (HFZ–410), Food and Drug

Administration, 9200 Corporate Blvd.,

Rockville, MD 20850, 301–594–1184,

ext. 176, or FDA Advisory Committee

Information Line, 1–800–741–8138

(301–443–0572 in the Washington, DC

area), code 12513. Please call the

Information Line or access the Internet

(http://www.fda.gov/cdrh/

panelmtg.html for up-to-date

information on this meeting.

Agenda: The committee will discuss

and make recommendations on: (1) The

design of clinical trials for devices to

prevent stroke, to treat stroke, and to

provide neurological protection after

stroke; and (2) the design of clinical

studies for temperature control devices

to provide neurological protection.

Procedure: On November 16, 2000,

from 10 a.m. to 7 p.m., the meeting is

open to the public. Interested persons

may present data, information, or views,

orally or in writing, on issues pending

before the committee. Written

submissions may be made to the contact

person by November 9, 2000. On

November 16, 2000, oral presentations

from the public will be scheduled

between approximately 11 a.m. and

11:30 a.m. for the discussion of the

design of clinical studies for devices to

prevent stroke, to treat stroke, and to

provide neurological protection after

stroke, and between approximately 4:30

p.m. and 5 p.m. for the discussion of the

design of clinical studies for

temperature control devices to provide

neurological protection. Time allotted

for each presentation may be limited.

Those desiring to make formal oral

presentations should notify the contact

person before November 9, 2000, and

submit a brief statement of the general

nature of the evidence or arguments

they wish to present, the names and

addresses of proposed participants, and

an indication of the approximate time

requested to make their presentation.

Closed Committee Deliberations: On

November 16, 2000, from 9:30 a.m. to 10

a.m., the meeting will be closed to

permit FDA to present to the committee

trade secret and/or confidential

commercial information (5 U.S.C.

552b(c)(4)) regarding pending issues and

applications.

FDA regrets that it was unable to

publish this notice 15 days prior to the

November 16, 2000, Neurological

Devices Panel of the Medical Devices

Advisory Committee meeting. Because

the agency believes there is some

urgency to bring these issues to public

discussion and qualified members of the

Neurological Devices Panel of the

Medical Devices Advisory Committee

were available at this time, the

Commissioner of Food and Drugs

concluded that it was in the public

interest to hold this meeting even if

there was not sufficient time for the

customary 15-day public notice.

Notice of this meeting is given under

the Federal Advisory Committee Act (5

U.S.C. app. 2).

Dated: October 31, 2000.

Linda A. Suydam,

Senior Associate Commissioner.

[FR Doc. 00–28445 Filed 11–1–00; 4:34 pm]

BILLING CODE 4160–01–F

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Center for Research

Resources; Notice of Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.